The number of biobanks around the world has increased dramatically, owing in part, to the need for researchers to have access to large numbers of samples for genomic research. Policies for enrolling participants, returning research results and obtaining samples and data can have a far reaching impact on the type of research that can be performed with each biobank. Research using biobank samples includes studies of the impact of environmental and other risk exposures on health, understanding genetic risks for common disease, identification of biomarkers in disease progression and prognosis, and implementation of personalized medicine projects. This research has been instrumental in the progress of genetic and genomic research and translational medicine. This article will highlight some of the controversies and recent research associated with biobanking over the past year.
CITATION STYLE
Smith, M. E., & Aufox, S. (2013). Biobanking: The Melding of Research with Clinical Care. Current Genetic Medicine Reports, 1(2), 122–128. https://doi.org/10.1007/s40142-013-0014-6
Mendeley helps you to discover research relevant for your work.